Alan Yeung, MD
Academic Appointments
- Professor - Med Center Line, Medicine - Cardiovascular Medicine
Contact Information
-
Clinical Offices
Cardiovascular Medicine Clinic 300 Pasteur Dr A260 MC 5319 Stanford, CA 94305-2200 Tel Work (650) 723-0180 Fax (650) 725-6766
- Academic Offices
Personal Information Tel (650) 723-0180Administrative Contact Tanya Carrasco Administrative Assistant Email Tel Work 650-723-0180Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cardiology (Heart)
- Cardiovascular Disease
- Coronary Artery Disease
- Chronic Total Occlusions
- Complex Coronary Angioplasty
Administrative Appointments
- Vice Chair, Department of Medicine, Stanford University School of Medicine (2008 - present)
- Chief(Clinical), Division of Cardiovascular Medicine, Stanford University School of Medicine (2000 - present)
- Director, Interventional Cardiology, Stanford University School of Medicine (1998 - present)
Honors and Awards
- Li Ka Shing Professor, Stanford University (2008)
Professional Education
| Board Certification: | Cardiovascular Disease, American Board of Internal Medicine (1989) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1987) |
| Fellowship: | Brigham and Women's Hospital, Harvard Medical School, MA (1990) |
| Board Certification: | Interventional Cardiology, American Board of Internal Medicine (2000) |
| Residency: | Massachusetts General Hospital, MA (1987) |
Postdoctoral Advisees
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Abbott Vascular , Boston Scientific Corp , Medtronic |
Scientific Focus
Research Interests
Coronary artery disease is the leading cause of death in men and women in the United States. Our group is interested in studying both the early and late phases of atherosclerosis so that we can better develop prevention and treatment strategies. Our current studies include:
1) non-invasive methods of assessing vascular endothelial function so that we can better stratefy high risk coronary artery disease patients.
2) structural and functional studies of atherosclerosis in transplant coronary artery disease patients in order to define the the relationship between the two.
3) intravascular ultrasound studies to define the time-course in the devlopment of transplant coronary disease.
4) development of novel techniques to devliver drug imbedded particles into the atherosclerotic wall.
5) study the restenosis process in a vivo pig model.
Clinical Trials
- FACILITATED ANTEGRADE STEERING TECHNIQUE IN CHRONIC TOTAL OCCLUSIONS (FAST-CTOs) CLINICAL STUDY Recruiting
- Safety and efficacy of using PROCHYMAL (a stem cell product) to treat acute heart attacks Recruiting
- Transcatheter Aortic Valve Replacement Recruiting
- Sex Differences in Coronary Pathophysiology Recruiting
Publications
- Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology. 2009; (1): 117-27
- The pre-clinical animal model in the translational research of interventional cardiology. JACC Cardiovasc Interv. 2009; (5): 373-83
- Development of animal model for calcified chronic total occlusion. Catheter Cardiovasc Interv. 2009; (3): 468-75
- Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. Am Heart J. 2008; (5): 889.e1-6
- The importance of pre-clinical animal testing in interventional cardiology. Arq Bras Cardiol. 2008; (5): 348-60

